Palmitic acid-induced apoptosis in pancreatic β-cells is increased by liver X receptor agonist and attenuated by eicosapentaenoate

In Vivo

Volumn 25, Issue 5, 2011, Pages 711-718

  Liang, Huasheng ^a   Zhong, Yuhua ^a   Zhou, Shaobi ^a   Li, Qingdi Quentin ^b,c  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Apoptosis; Eicosapentaenoate; INS 1 cells; Liver X receptors; Palmitic acid; SREBP 1

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ICOSAPENTAENOIC ACID; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PALMITIC ACID; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; SMAD3 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; DRUG MECHANISM; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; UPREGULATION;

EID: 79960642095     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ichinose K, Kawasaki E and Eguchi K: Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am J Nephrol 27: 554-564, 2007. (Pubitemid 350014942)
2. Faas FH and Carter WJ: Altered microsomal phospholipid composition in the streptozotocin diabetic rat. Lipids 18: 339-342, 1983.
3. Mercuri O, Peluffo RO and Brenner RR: Effect of insulin on the oxidative desaturation of α-linolenic, oleic and palmitic acids. Lipids 2: 284-285, 1967.
4. Ramesh B, Viswanathan P and Pugalendi KV: Protective effect of umbelliferone on membranous fatty acid composition in streptozotocin-induced diabetic rats. Eur J Pharmacol 566: 231-239, 2007.
5. Folsom AR, Ma J, McGovern PG and Eckfeldt H: Relation between plasma phospholipid saturated fatty acids and hyperinsulinemia. Metabolism 45: 223-228, 1996. (Pubitemid 26102621)
6. Itani SI, Zhou Q, Pories WJ, MacDonald KG and Dohm GL: Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 49: 1353-1358, 2000. (Pubitemid 30624237)
7. Sabin MA, Stewart CE, Crowne EC, Turner SJ, Hunt LP, Welsh GI, Grohmann MJ, Holly JM and Shield JP: Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid. J Cell Physiol 211: 244-252, 2007.
8. Hommelberg PP, Plat J, Langen RC, Schols AM and Mensink RP: Fatty acid-induced NF-κB activation and insulin resistance in skeletal muscle are chain length-dependent. Am J Physiol Endocrinol Metab 296: E114-120, 2009.
9. Poitout V: β-Cell lipotoxicity: burning fat into heat? Endocrinology 145: 3563-3565, 2004.
10. Kakuma T, Lee Y, Higa M, Wang Z, Pan W, Shimomura I and Unger RH: Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci USA 97: 8536-8541, 2000. (Pubitemid 30639708)
11. Hao M, Head WS, Gunawardana SC, Hasty AH and Piston DW: Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic β-cell dysfunction. Diabetes 56: 2328-2338, 2007.
12. Wensaas AJ, Rustan AC, Just M, Berge RK, Drevon CA and Gaster M: Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of β-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid. Diabetes 58: 527-535, 2009.
13. Dembele K, Nguyen KH, Hernandez TA and Nyomba BL: Effects of ethanol on pancreatic β-cell death: interaction with glucose and fatty acids. Cell Biol Toxicol 25: 141-152, 2009.
14. Salinari S, Bertuzzi A, Iaconelli A, Manco M and Mingrone G: Twenty-four hour insulin secretion and β-cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery. Diabetologia 51: 1276-1284, 2008.
15. Rippmann JF, Schoelch C, Nolte T, Pavliska H, van Marie A, van Es H and Prestle J: Improved lipid profile through liver-specific knockdown of liver X receptor-α in KKAy diabetic mice. J Lipid Res 50: 22-31, 2009.
16. Dahlman I, Nilsson M, Gu HF, Lecoeur C, Efendic S, Ostenson CG, Brismar K, Gustafsson JA, Froguel P, Vaxillaire M, Dahlman-Wright K and Steffensen KR: Functional and genetic analysis in type 2 diabetes of liver X receptor alleles-a cohort study. BMC Med Genet 10: 27-35, 2009.
17. Wang H, Maechler P, Antinozzi PA, Herrero L, Hagenfeldt-Johansson KA, Bjorklund A and Wollheim CB: The transcription factor SREBP-1c is instrumental in the development of β-cell dysfunction. J Biol Chem 278: 16622-16629, 2003. (Pubitemid 36799525)
18. Takahashi A, Motomura K, Kato T, Yoshikawa T, Nakagawa Y, Yahagi N, Sone H, Suzuki H, Toyoshima H, Yamada N and Shimano H: Transgenic mice overexpressing nuclear SREBP-1c in pancreatic β-cells. Diabetes 54: 492-499, 2005.
19. Westerveld HT, de Graaf JC, van Breugel HH, Akkerman JW, Sixma JJ, Erkelens DW and Banga JD: Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM. Diabetes Care 16: 683-688, 1993.
20. Satoh N, Shimatsu A, Kotani K, Sakane N, Yamada K, Suganami T, Kuzuya H and Ogawa Y: Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diabetes Care 30: 144-146, 2007. (Pubitemid 46061295)
21. Shimizu H, Ohtani K, Tanaka Y, Sato N, Mori M and Shimomura Y: Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients. Diabetes Res Clin Pract 28: 35-40, 1995.
22. Zhang M, Hagiwara S, Matsumoto M, Gu L, Tanimoto M, Nakamura S, Kaneko S, Gohda T, Qian J, Horikoshi S and Tomino Y: Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress. Metabolism 55: 1590-1598, 2006. (Pubitemid 44827124)
23. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL and Mangelsdorf DJ: Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev 14: 2819-2830, 2000.
24. Steffensen KR and Gustafsson JA: Putative metabolic effects of the liver X receptor (LXR). Diabetes 53(Suppl 1): S36-42, 2004.
25. Janowski BA, Willy PJ, Devi TR, Falck JR and Mangelsdorf DJ: An oxysterol signalling pathway mediated by the nuclear receptor LXRα. Nature 383: 728-731, 1996. (Pubitemid 26360651)
26. Baranowski M: Biological role of liver X receptors. J Physiol Pharmacol 59(Suppl 7): 31-55, 2008.
27. Liu Y, Yan C, Wang Y, Nakagawa Y, Nerio N, Anghel A, Lutfy K and Friedman TC: Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. Endocrinology 147: 5061-5068, 2006. (Pubitemid 44790557)
28. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, Collins JL, Osborne TF and Tontonoz P: Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 277: 11019-11025, 2002. (Pubitemid 34952859)
29. Seo JB, Moon HM, Kim WS, Lee YS, Jeong HW, Yoo EJ, Ham J, Kang H, Park MG, Steffensen KR, Stulnig TM, Gustafsson JA, Park SD and Kim JB: Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor-γ expression. Mol Cell Biol 24: 3430-3444, 2004. (Pubitemid 38455438)
30. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD and Shan B: Role of LXRs in control of lipogenesis. Genes Dev 14: 2831-2838, 2000.
31. Fernandez-Veledo S, Nieto-Vazquez I, de Castro J, Ramos MP, Bruderlein S, Moller P and Lorenzo M: Hyperinsulinemia induces insulin resistance on glucose and lipid metabolism in a human adipocytic cell line: paracrine interaction with myocytes. J Clin Endocrinol Metab 93: 2866-2876, 2008. (Pubitemid 352008563)
32. Choe SS, Choi AH, Lee JW, Kim KH, Chung JJ, Park J, Lee KM, Park KG, Lee IK and Kim JB: Chronic activation of liver X receptor induces β-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic ~β-cells. Diabetes 56: 1534-1543, 2007. (Pubitemid 46842606)
33. Efanov AM, Sewing S, Bokvist K and Gromada J: Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic β-cells. Diabetes 53(Suppl 3): S75-78, 2004.
34. Zitzer H, Wente W, Brenner MB, Sewing S, Buschard K, Gromada J and Efanov AM: Sterol regulatory element-binding protein 1 mediates liver X receptor-β-induced increases in insulin secretion and insulin messenger ribonucleic acid levels. Endocrinology 147: 3898-3905, 2006. (Pubitemid 44079395)
35. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA and Butler PC: β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110, 2003. (Pubitemid 36042113)
36. 2+ homeostasis revealed by RNA silencing. Diabetes 53: 393-400, 2004.
37. Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect of β-elemene in non-small cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 62: 881-893, 2005. (Pubitemid 40655635)
38. Cvjeticanin T, Stojanovic I, Timotijevic G, Stosic-Grujicic S and Miljkovic D: T-Cells cooperate with palmitic acid in induction of β-cell apoptosis. BMC Immunol 10: 29-35, 2009.
39. Wente W, Brenner MB, Zitzer H, Gromada J and Efanov AM: Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells. Endocrinology 148: 1843-1849, 2007.
40. Li QQ, Wang G, Zhang M, Cuff CF, Huang L and Reed E: β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol Rep 22: 161-170, 2009.
41. Li QQ, Wang G, Reed E, Huang L and Cuff CF: Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy. Basic Clin Pharmacol Toxicol 107: 868-876, 2010.
42. Li QQ, Wang G, Huang F, Banda M and Reed E: Antineoplastic effect of β-elemene on prostate cancer cells and other types of solid tumour cells. J Pharm Pharmacol 62: 1018-1027, 2010.
43. Kato T, Shimano H, Yamamoto T, Ishikawa M, Kumadaki S, Matsuzaka T, Nakagawa Y, Yahagi N, Nakakuki M, Hasty AH, Takeuchi Y, Kobayashi K, Takahashi A, Yatoh S, Suzuki H, Sone H and Yamada N: Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Diabetes 57: 2382-2392, 2008.
44. Chisholm JW, Hong J, Mills SA and Lawn RM: The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J Lipid Res 44: 2039-2048, 2003. (Pubitemid 37509619)
45. Meng ZX, Nie J, Ling JJ, Sun JX, Zhu YX, Gao L, Lv JH, Zhu DY, Sun YJ and Han X: Activation of liver X receptors inhibits pancreatic islet β-cell proliferation through cell cycle arrest. Diabetologia 52: 125-135, 2009.
46. Landau Z, Forti E, Alcaly M and Birk RZ: Palmitate induced lipoapoptosis of exocrine pancreas AR42J cells. Apoptosis 11: 717-724, 2006. (Pubitemid 43876841)
47. Morgan D, Oliveira-Emilio HR, Keane D, Hirata AE, Santos da Rocha M, Bordin S, Curi R, Newsholme P and Carpinelli AR: Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal β-cell line. Diabetologia 50: 359-369, 2007.
48. Stentz FB and Kitabchi AE: Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation. Biochem Biophys Res Commun 346: 721-726, 2006.
49. Wagner BL, Valledor AF, Shao G, Daige CL, Bischoff ED, Petrowski M, Jepsen K, Baek SH, Heyman RA, Rosenfeld MG, Schulman IG and Glass CK: Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol 23: 5780-5789, 2003. (Pubitemid 36951340)
50. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML and Prentki M: Fatty acid signaling in the β-cell and insulin secretion. Diabetes 55(Suppl 2): S16-23, 2006.
51. Vedin LL, Lewandowski SA, Parini P, Gustafsson JA and Steffensen KR: The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 30: 575-579, 2009.